These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23444930)

  • 1. Landmarks in hormonal therapy for prostate cancer.
    Tombal B; Crawford ED
    BJU Int; 2013 Mar; 111(3):E12-3. PubMed ID: 23444930
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply: Landmarks in hormonal therapy for prostate cancer.
    Hammerer P; Madersbacher S
    BJU Int; 2013 Mar; 111(3):E13-5. PubMed ID: 23444931
    [No Abstract]   [Full Text] [Related]  

  • 3. Global update on the use of hormonal therapy for the management of high-risk prostate cancer: introduction.
    Gomella LG
    BJU Int; 2007 Jan; 99 Suppl 1():1. PubMed ID: 17229158
    [No Abstract]   [Full Text] [Related]  

  • 4. Androgen suppression plus radiation for prostate cancer.
    Millar J
    JAMA; 2004 Dec; 292(21):2581-2; author reply 2582. PubMed ID: 15572714
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary androgen deprivation therapy in men with prostate cancer.
    Laufman L
    JAMA; 2009 Jan; 301(1):35; author reply 35. PubMed ID: 19126809
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of radiation and androgen deprivation therapy for advanced prostate cancer.
    Jani AB; Rossi PJ
    Curr Probl Cancer; 2015; 39(1):41-7. PubMed ID: 25554467
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormone therapy for prostate cancer: what have we done with Charles Huggins' legacy?
    Tombal B
    Eur Urol; 2012 Jan; 61(1):26-8. PubMed ID: 21940097
    [No Abstract]   [Full Text] [Related]  

  • 8. Androgen-independent prostate cancer: a growth area?
    Wyllie MG
    BJU Int; 2003 Dec; 92(9):1037-8. PubMed ID: 14632870
    [No Abstract]   [Full Text] [Related]  

  • 9. Radiation therapy and androgen suppression as treatment for clinically localized prostate cancer: the new standard?
    DeWeese TL
    JAMA; 2004 Aug; 292(7):864-6. PubMed ID: 15316002
    [No Abstract]   [Full Text] [Related]  

  • 10. Monotherapy versus combined androgen blockade in patients with advanced prostate cancer.
    Errejon A; Crawford ED
    Cancer; 2002 Jul; 95(2):209-10. PubMed ID: 12124816
    [No Abstract]   [Full Text] [Related]  

  • 11. How early is early: androgen deprivation for prostate-specific antigen relapse in prostate cancer.
    Duchesne GM; Syme R; Howell D
    J Clin Oncol; 2006 Jun; 24(18):2964; author reply 2965. PubMed ID: 16782936
    [No Abstract]   [Full Text] [Related]  

  • 12. RE: Androgen Deprivation With or Without Radiation Therapy for Clinically Node-Positive Prostate Cancer.
    Briganti A; Gandaglia G; Fossati N; Moschini M; Montorsi F
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26209710
    [No Abstract]   [Full Text] [Related]  

  • 13. Does Radiotherapy Plus Androgen-Deprivation Therapy Represent the Best Treatment Approach in Elderly Patients With Locally Advanced Prostate Cancer?
    Gandaglia G; Fossati N; Montorsi F; Briganti A
    J Clin Oncol; 2015 Sep; 33(25):2831-2. PubMed ID: 26215938
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormonal treatment of prostate cancer.
    Garnick MB
    N Engl J Med; 1999 Mar; 340(10):812-3. PubMed ID: 10075531
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate cancer: Increased dementia risk following androgen deprivation therapy?
    Martins RN; Gandy S
    Nat Rev Urol; 2016 Apr; 13(4):188-9. PubMed ID: 26902342
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormonal therapy options for prostate-specific antigen-only recurrence of prostate cancer after previous local therapy.
    Moul JW; Zlotta AR
    BJU Int; 2005 Feb; 95(3):285-90. PubMed ID: 15679779
    [No Abstract]   [Full Text] [Related]  

  • 17. Treating asymptomatic patients with hormone-refractory prostate cancer: hormonal manipulations for the urologist.
    Boudreaux KJ; Chang SS
    BJU Int; 2008 Mar; 101(6):671-4. PubMed ID: 18070172
    [No Abstract]   [Full Text] [Related]  

  • 18. Words of Wisdom. Re: Androgen Deprivation With or Without Radiation Therapy for Clinically Node-Positive Prostate Cancer.
    Isbarn H
    Eur Urol; 2016 Feb; 69(2):372-3. PubMed ID: 26758519
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of the hormone sensitivity of prostate cancer: where are we now?
    Alcaraz A
    Eur Urol; 2008 Aug; 54(2):247-50; discussion 250-1. PubMed ID: 18343562
    [No Abstract]   [Full Text] [Related]  

  • 20. Secondary hormonal therapy for prostate cancer: what lies on the horizon?
    Sharifi N; Dahut WL; Figg WD
    BJU Int; 2008 Feb; 101(3):271-4. PubMed ID: 17922868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.